AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AVITA Medical to Host Investor Webinar Briefing on Q2 Earnings
ByAinvest
Monday, Aug 11, 2025 4:35 pm ET1min read
AVITA Medical will host an investor webinar on August 14, 2025, to discuss its second-quarter financial results. CEO Jim Corbett and CFO David O'Toole will present and answer questions. The webinar will be available for replay on the company's investor relations website. AVITA Medical specializes in acute wound care and has FDA-approved products like the RECELL System and Spray-On Skin Cells.
AVITA Medical (NASDAQ: RCEL), a leading therapeutic acute wound care company, will host an investor webinar on August 14, 2025, to discuss its second-quarter financial results. The presentation will feature CEO Jim Corbett and CFO David O'Toole, who will provide insights into the company's performance and answer questions from investors [2].The webinar will cover AVITA Medical's Q2 2025 financial and business results, including its revenue growth and adjusted financial guidance. The company reported a 21.2% increase in total revenue to $18.42 million, driven by strong commercial sales. However, the company narrowed its net loss by 35.6% to $9.92 million, reflecting ongoing operational challenges [1].
Despite the revenue growth, AVITA Medical revised its full-year 2025 revenue guidance to a range of $76 million to $81 million, a 19% to 27% increase over 2024. This reduction was attributed to a 20% decline in RECELL demand during the first half of 2025 due to the reimbursement backlog [1].
The webinar will also discuss the company's strategic direction and product portfolio, which includes the FDA-approved RECELL System and Spray-On Skin Cells. The RECELL System harnesses the healing properties of a patient's own skin to create Spray-On Skin Cells, offering an innovative solution for improved clinical outcomes at the point-of-care [2].
Investors are encouraged to attend the webinar and submit their questions through the registration page. A replay will be available on AVITA Medical's investor relations website following the presentation [2].
References:
[1] https://www.ainvest.com/news/avita-medical-2025-q2-earnings-narrowed-losses-revenues-guidance-cut-2508/
[2] https://www.stocktitan.net/news/RCEL/avita-medical-to-host-investor-webinar-hhsoimnv4o5b.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet